Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenzhuan Xie
Observed names:
W J Xie,
W. Xie,
Wen-Zhuan Xie,
Xie, Wenzhuan,
wenzhuan Xie
Institutions:
Guangxi Medical University,
Tumor Hospital of Guangxi Medical University
Observed institutions:
Guangxi Medical University,
Burning Rock Biotech (China),
Zhujiang Hospital,
Tumor Hospital of Guangxi Medical University,
3D Medicines, Inc. (China),
Southern Medical University
show all 6
ORCID:
0000-0002-2472-0286
Observed ORCID:
0000-0002-2472-0286
OpenAlex ID:
A5078600712
A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma
2020
·
Taicheng Zhou
, Zhihua Cai
, et al.
·
Frontiers in Cell and Developmental Biology
·
83
PDF
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING
2021
·
Yong Zhang
, Qifan Yang
, et al.
·
Cancer Discovery
·
82
PDF
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer
2021
·
Jian Xiao
, Wenyun Li
, et al.
·
BMC Cancer
·
77
PDF
Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
2021
·
Guozhen Yang
, Xiaodong Su
, et al.
·
Annals of Translational Medicine
·
54
PDF
EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma
2020
·
Hua Bai
, Jianchun Duan
, et al.
·
Journal for ImmunoTherapy of Cancer
·
34
PDF
KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials
2021
·
Hongyuan Zhu
, Daipeng Xie
, et al.
·
Frontiers in Oncology
·
26
PDF
Comprehensive analysis of DNA damage repair deficiency in 10,284 pan-cancer study
2021
·
Yanni Xiao
, Di Lu
, et al.
·
Annals of Translational Medicine
·
22
Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer
2020
·
Rusi Zhang
, Xuewen Zhang
, et al.
·
Translational Lung Cancer Research
·
13
The Predictive Value of MAP2K1/2 Mutations on Efficiency of Immunotherapy in Melanoma
2022
·
Ting Ye
, Jie-Ying Zhang
, et al.
·
Frontiers in Immunology
·
9
PDF
Hepatocellular carcinoma with ARID1A mutation is associated with higher TMB and poor survival.
2020
·
Yaorong Peng
, Bowen Gao
, et al.
·
Journal of Clinical Oncology
·
9
Primary Resistance to Brigatinib in a Patient with Lung Adenocarcinoma Harboring ALK G1202R Mutation and LIPI-NTRK1 Rearrangement
2020
·
Zhiwei Xiao
, Xuewu Huang
, et al.
·
OncoTargets and Therapy
·
8
PDF
Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis.
1991
·
S J Chen
, Q Wang
, et al.
·
PubMed
·
8
KEAP1/NFE2L2 as a prognostic biomarker on immunotherapy and correlation with immune infiltrates in non-small cell lung cancer (NSCLC).
2020
·
Hongyuan Zhu
, Yunfang Yu
, et al.
·
Journal of Clinical Oncology
·
6
Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma
2021
·
Yongjian Zheng
, Yuan Cheng
, et al.
·
Journal of Gastrointestinal Oncology
·
5
PDF
Chromosome 8q24 amplification predicts prognosis for patients with advanced hepatocellular carcinoma (HCC).
2019
·
Yuan Cheng
, Mengli Huang
, et al.
·
Journal of Clinical Oncology
·
4
A pan-cancer analysis of ARID1A as a potential biomarker for immune checkpoint therapy.
2020
·
Dongyong Yang
, Yuan Xu
, et al.
·
Journal of Clinical Oncology
·
3
Association between MUC5B mutation and prognosis across solid tumors.
2020
·
Qun Zhao
, Hong Zheng
, et al.
·
Journal of Clinical Oncology
·
3
Abstract 2236: A Pan-cancer Analysis of CREBBP as a potential predictor for immune checkpoint therapy
2021
·
Jiaping Li
, Wenzhe Fan
, et al.
·
Cancer Research
·
2
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with metastatic breast cancer.
2019
·
Xiaoxiang Guan
, Hong Zhu
, et al.
·
Journal of Clinical Oncology
·
2
Variant allele frequency of circulating tumor DNA mutations detected in preoperative blood is indicator for lymph node metastasis in early stage lung cancer.
2020
·
Rusi Zhang
, Xinyi Liu
, et al.
·
Journal of Clinical Oncology
·
1
A pan-cancer analysis of microsatellite instability as a predictor of Lynch syndrome in Chinese population.
2019
·
Pinzhu Huang
, Yanhong Deng
, et al.
·
Journal of Clinical Oncology
·
1
Nutrition-Related Hematological and Body Composition Biomarkers in Stage III Unresectable NSCLC Treated with Immunochemoradiotherapy: A Retrospective Cohort Study
2025
·
X. Gan
, J. Fang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
557P First clinical data of DB-1305/BNT325 (TROP2 antibody-drug conjugate [ADC]) in patients (pts) with pretreated triple-negative breast cancer (TNBC): Efficacy and safety data from a phase I/II trial
2025
·
E. Hamilton
, M. Yan
, et al.
·
Annals of Oncology
P2.11A.06 Tumor-Informed ctDNA Status Guiding 1st-line Immuno-Chemotherapy in Advanced NSCLC: CHOICE-01 Retrospective Analysis
2024
·
Z. Wang
, J. Zhong
, et al.
·
Journal of Thoracic Oncology
PDF
Table S2 from MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING
2023
·
Yong Zhang
, Qifan Yang
, et al.
Show more works
View as search
Works count:
79
Citation count:
452
H-index:
9
I10-index:
8
Year
Topic
Type
